FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session Two

This annual training course provided participants with the essential knowledge and skills to conduct clinical trials effectively, ethically, and in accordance with regulatory standards. Session two of day one covered topics such as safety considerations in clinical drug development and specific populations in clinical trials.
01:40 - Safety Considerations in Clinical Drug Development
46:46 - Specific Populations in Clinical Trials
01:14:00 - Q&A Discussion Panel
Speakers | Panelists
Shabnam Naseer, DO, MMS
Lead Physician
Division of Anti-Infectives (DAI)
Office of Infectious Diseases (OID)
Office of New Drugs (OND)
CDER | FDA
Lynne Yao, MD
Director
Division of Pediatrics and Maternal Health (DPMH)
Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine (ORPURM)
OND | CDER | FDA
(Moderator)
Leonard Sacks, MBBCh
Associate Director for Clinical Methodologies
Office of Medical Policy (OMP)
CDER | FDA
Learn more at: www.fda.gov/dr...
-----------------------
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming Training - www.fda.gov/cd...
SBIA Listserv - public.govdeli...
SBIA 2024 Playlist - • 2024 CDER Small Busine...
SBIA LinkedIn -  / cder-small-business-an...
SBIA Training Resources - www.fda.gov/cd...
Twitter -  / fda_drug_info
Email - [e-mail]
Phone - [phone] I [phone]